title: Vibrio cholerae ToxR downregulates virulence factor production in response to cyclo(Phe-Pro).
abstract: Vibrio cholerae is an aquatic organism that causes the severe acute diarrheal disease cholera. The ability of V. cholerae to cause disease is dependent upon the production of two critical virulence determinants, cholera toxin (CT) and the toxin-coregulated pilus (TCP). The expression of the genes that encode for CT and TCP production is under the control of a hierarchical regulatory system called the ToxR regulon, which functions to activate virulence gene expression in response to in vivo stimuli. Cyclic dipeptides have been found to be produced by numerous bacteria, yet their biological function remains unknown. V. cholerae has been shown to produce cyclo(Phe-Pro). Previous studies in our laboratory demonstrated that cyclo(Phe-Pro) inhibited V. cholerae virulence factor production. For this study, we report on the mechanism by which cyclo(Phe-Pro) inhibited virulence factor production. We have demonstrated that exogenous cyclo(Phe-Pro) activated the expression of leuO, a LysR-family regulator that had not been previously associated with V. cholerae virulence. Increased leuO expression repressed aphA transcription, which resulted in downregulation of the ToxR regulon and attenuated CT and TCP production. The cyclo(Phe-Pro)-dependent induction of leuO expression was found to be dependent upon the virulence regulator ToxR. Cyclo(Phe-Pro) did not affect toxR transcription or ToxR protein levels but appeared to enhance the ToxR-dependent transcription of leuO. These results have identified leuO as a new component of the ToxR regulon and demonstrate for the first time that ToxR is capable of downregulating virulence gene expression in response to an environmental cue.
  
  
  OBJECTIVE
  The ToxR regulon has been a focus of cholera research for more than three decades. During this time, a model has emerged wherein ToxR functions to activate the expression of Vibrio cholerae virulence factors upon host entry. V. cholerae and other enteric bacteria produce cyclo(Phe-Pro), a cyclic dipeptide that we identified as an inhibitor of V. cholerae virulence factor production. This finding suggested that cyclo(Phe-Pro) was a negative effector of virulence factor production and represented a molecule that could potentially be exploited for therapeutic development. In this work, we investigated the mechanism by which cyclo(Phe-Pro) inhibited virulence factor production. We found that cyclo(Phe-Pro) signaled through ToxR to activate the expression of leuO, a new virulence regulator that functioned to repress virulence factor production. Our results have identified a new arm of the ToxR regulon and suggest that ToxR may play a broader role in pathogenesis than previously known.
authors: Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
authors: X Renee
authors: XR
authors: Bina
authors: Dawn L
authors: DL
authors: Taylor
authors: Amit
authors: A
authors: Vikram
authors: Vanessa M
authors: VM
authors: Ante
authors: James E
authors: JE
authors: Bina
mesh_terms: D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D002771:Cholera / Q000382:microbiology*; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D004151:Dipeptides / Q000378:metabolism*; D015536:Down-Regulation; D005260:Female; D015964:Gene Expression Regulation, Bacterial; D006801:Humans; D008297:Male; D051379:Mice; D010456:Peptides, Cyclic / Q000378:metabolism*; D018085:Regulon; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D014734:Vibrio cholerae / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity; D014774:Virulence; D037521:Virulence Factors / Q000235:genetics / Q000378:metabolism*
chemical_list: D001426:Bacterial Proteins; D004268:DNA-Binding Proteins; D004151:Dipeptides; D010456:Peptides, Cyclic; D014157:Transcription Factors; D037521:Virulence Factors; C118540:cyclo(phenylalanyl-prolyl); C499324:toxR protein, Vibrio cholerae
references: Gene. 1980 Jan;8(2):135-52
references: 6987127
references: Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3465-70
references: 15728357
references: PLoS One. 2012;7(5):e38208
references: 22666485
references: PLoS Pathog. 2010 Sep 16;6(9):e1001102
references: 20862321
references: Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):730-4
references: 9435261
references: Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5403-7
references: 2052618
references: FEMS Microbiol Rev. 2005 Nov;29(5):935-47
references: 16219513
references: J Bacteriol. 2010 Sep;192(17):4300-10
references: 20601467
references: Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16403-8
references: 16254052
references: Mol Microbiol. 2005 Sep;57(6):1623-35
references: 16135229
references: J Bacteriol. 2011 Feb;193(4):979-88
references: 21169492
references: Curr Microbiol. 2002 Oct;45(4):250-4
references: 12192521
references: Cell Host Microbe. 2007 Oct 11;2(4):264-77
references: 18005744
references: J Bacteriol. 1999 Jul;181(14):4250-6
references: 10400582
references: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1286-91
references: 12552086
references: Mol Microbiol. 2011 Sep;81(6):1640-53
references: 21883522
references: Mol Microbiol. 2011 Oct;82(2):378-97
references: 21883529
references: Mol Microbiol. 2012 Feb;83(3):599-611
references: 22229925
references: Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3129-34
references: 11854465
references: Future Microbiol. 2007 Jun;2(3):335-44
references: 17661707
references: Mol Microbiol. 1999 Sep;33(6):1254-66
references: 10510239
references: Nature. 2002 Jun 6;417(6889):642-5
references: 12050664
references: Infect Immun. 2001 Jul;69(7):4681-5
references: 11402016
references: FEMS Immunol Med Microbiol. 2009 Oct;57(1):69-79
references: 19678844
references: Infect Immun. 2008 Aug;76(8):3595-605
references: 18490456
references: Mol Microbiol. 1997 Sep;25(6):1003-9
references: 9350858
references: Cell. 1987 Jan 30;48(2):271-9
references: 3802195
references: Environ Microbiol Rep. 2011 Apr;3(2):218-222
references: 21643457
references: J Bacteriol. 2010 Jul;192(14):3829-32
references: 20453095
references: J Bacteriol. 2006 Mar;188(6):2214-21
references: 16513751
references: Mol Microbiol. 2012 Sep;85(6):1072-89
references: 22804842
references: Infect Immun. 2012 May;80(5):1834-45
references: 22392925
references: Infect Immun. 2005 Aug;73(8):4488-93
references: 16040959
references: Clin Microbiol Rev. 1995 Jan;8(1):48-86
references: 7704895
references: J Bacteriol. 1988 Jun;170(6):2575-83
references: 2836362
references: J Biol Chem. 2001 Jun 1;276(22):19046-51
references: 11376008
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Peptides. 1995;16(1):151-64
references: 7716068
references: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2801-6
references: 12601157
references: Mol Microbiol. 2003 Oct;50(2):427-44
references: 14617169
references: Curr Issues Intest Microbiol. 2002 Sep;3(2):29-38
references: 12400636
references: Proc Natl Acad Sci U S A. 1987 May;84(9):2833-7
references: 2883655
references: Arch Microbiol. 2006 Sep;186(3):171-81
references: 16804679
references: Nucleic Acids Res. 1991 May 25;19(10):2785
references: 1645866
references: Mol Microbiol. 2000 Jan;35(1):189-203
references: 10632889
references: Infect Immun. 2013 Mar;81(3):884-95
references: 23297386
references: J Bacteriol. 2000 Aug;182(15):4295-303
references: 10894740
references: J Bacteriol. 2004 Dec;186(24):8309-16
references: 15576780
references: Mol Microbiol. 2003 Mar;47(5):1459-73
references: 12603748
references: Methods Enzymol. 1994;235:517-26
references: 8057923
references: Mol Microbiol. 1999 Feb;31(3):763-71
references: 10048021
references: Infect Immun. 2006 Feb;74(2):1141-7
references: 16428762
references: PLoS One. 2012;7(10):e47756
references: 23144706
references: J Bacteriol. 2010 Nov;192(22):6025-38
references: 20851895